Provided by Tiger Fintech (Singapore) Pte. Ltd.

Champions Oncology

7.90
+0.29003.81%
Post-market: 7.900.00000.00%16:05 EDT
Volume:26.75K
Turnover:213.72K
Market Cap:108.28M
PE:17.27
High:8.20
Open:8.14
Low:7.88
Close:7.61
Loading ...

Company Profile

Company Name:
Champions Oncology
Exchange:
NASDAQ
Establishment Date:
1985
Employees:
- -
Office Location:
One University Plaza,Suite 307,Hackensack,New Jersey,United States
Zip Code:
07601
Fax:
- -
Introduction:
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Directors

Name
Position
Joel Ackerman
Chairman of the Board
Ronnie Morris
Chief Executive Officer and Director
David Sidransky
Lead Director
Daniel N. Mendelson
Director
Philip Breitfeld
Director
Robert Brainin
Director
Scott R. Tobin
Director

Shareholders

Name
Position
Ronnie Morris
Chief Executive Officer and Director
David Miller
Chief Financial Officer